Mesenchymal stem cells attenuate liver fibrosis by suppressing Th17 cells - an experimental study.

Milosavljevic, Neda; Gazdic, Marina; Simovic Markovic, Bojana; Arsenijevic, Aleksandar; Nurkovic, Jasmin; Dolicanin, Zana; Jovicic, Nemanja; Jeftic, Ilija; Djonov, Valentin; Arsenijevic, Nebojsa; Lukic, Miodrag L; Volarevic, Vladislav (2018). Mesenchymal stem cells attenuate liver fibrosis by suppressing Th17 cells - an experimental study. Transplant international, 31(1), pp. 102-115. Wiley-Blackwell 10.1111/tri.13023

[img] Text
tri13023.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (1MB) | Request a copy

This study investigates molecular and cellular mechanisms involved in mesenchymal stem cell (MSC)-mediated modulation of IL-17 signaling during liver fibrosis. Mice received CCl4 (1 μl/g intraperitoneally) twice/week for 1 month. MSCs (1 × 106 ), or MSC-conditioned medium (MSC-CM), were intravenously injected 24 h after CCl4 and on every 7th day. Liver fibrosis was determined by macroscopic examination, histological analysis, Sirius red staining, and RT-PCR. Serum levels of cytokines, indoleamine 2,3-dioxygenase (IDO), and kynurenine were determined by ELISA. Flow cytometry was performed to identify liver-infiltrated cells. In vitro, CD4+ T cells were stimulated and cultured with MSCs. 1-methyltryptophan was used for inhibition of IDO. MSCs significantly attenuated CCl4 -induced liver fibrosis by decreasing serum levels of inflammatory IL-17, increasing immunosuppressive IL-10, IDO, and kynurenine, reducing number of IL-17 producing Th17 cells, and increasing percentage of CD4+ IL-10+ T cells. Injection of MSC-CM resulted with attenuated fibrosis accompanied with the reduced number of Th17 cells in the liver and decreased serum levels of IL-17. MSC-CM promoted expansion of CD4+ FoxP3+ IL-10+ T regulatory cells and suppressed proliferation of Th17 cells. This phenomenon was completely abrogated in the presence of IDO inhibitor. MSCs, in IDO-dependent manner, suppress liver Th17 cells which lead to the attenuation of liver fibrosis.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Anatomy
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Anatomy > Topographical and Clinical Anatomy

UniBE Contributor:

Djonov, Valentin

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0934-0874

Publisher:

Wiley-Blackwell

Language:

English

Submitter:

David Christian Haberthür

Date Deposited:

06 Apr 2018 14:52

Last Modified:

06 Apr 2018 14:52

Publisher DOI:

10.1111/tri.13023

PubMed ID:

28805262

Uncontrolled Keywords:

CD4+ T cells IL-17 fibrosis liver mesenchymal stem cells

BORIS DOI:

10.7892/boris.109004

URI:

https://boris.unibe.ch/id/eprint/109004

Actions (login required)

Edit item Edit item
Provide Feedback